Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings https://ir.acurxpharma.com/section-16-filings/rss Acurx Pharmaceuticals, Inc. (ACXP) - Section 16 Filings en-us https://d1io3yog0oux5.cloudfront.net/_c16b21a2a7e58f1689d6a0a25dcc7dc6/acurxpharma/logo.png Acurx Pharmaceuticals, Inc. Logo https://ir.acurxpharma.com Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-509-0001104659-26-046846 Wed, 22 Apr 26 16:21:45 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-509-0001104659-26-046846 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-508-0001104659-26-046844 Wed, 22 Apr 26 16:21:03 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-508-0001104659-26-046844 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-507-0001104659-26-046842 Wed, 22 Apr 26 16:20:42 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-507-0001104659-26-046842 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-506-0001104659-26-046840 Wed, 22 Apr 26 16:20:34 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-506-0001104659-26-046840 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-505-0001104659-26-046837 Wed, 22 Apr 26 16:19:26 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-505-0001104659-26-046837 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-504-0001104659-26-046836 Wed, 22 Apr 26 16:18:46 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-504-0001104659-26-046836 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-503-0001104659-26-046835 Wed, 22 Apr 26 16:18:20 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-503-0001104659-26-046835 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-502-0001104659-26-046833 Wed, 22 Apr 26 16:17:03 -0400 https://ir.acurxpharma.com/section-16-filings?page=1#document-502-0001104659-26-046833 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-353-0001104659-25-010181 Thu, 06 Feb 25 17:48:20 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-353-0001104659-25-010181 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/section-16-filings?page=1#document-352-0001104659-25-010180 Thu, 06 Feb 25 17:47:19 -0500 https://ir.acurxpharma.com/section-16-filings?page=1#document-352-0001104659-25-010180